![Edgar A. Jaimes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edgar A. Jaimes
Nessuna posizione attualmente
Profilo
Edgar A.
Jaimes is the founder of Goldilocks Therapeutics, Inc. where he currently holds the title of Chairman & Chief Medical Officer.
The company was founded in 2018.
Precedenti posizioni note di Edgar A. Jaimes
Società | Posizione | Fine |
---|---|---|
Goldilocks Therapeutics, Inc.
![]() Goldilocks Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Goldilocks Therapeutics, Inc. engages in the development of drug delivery technology for kidney tubules. It offers treatment for acute kidney injury (AKI), polycystic kidney disease (PKD), and other under-treated kidney conditions by leveraging the Company’s proprietary mesoscale nanoparticles (MNPs). The company was founded by Arthur J. Klausner, Daniel A. Heller, and Edgar A. Jaimes in 2018 and is headquartered in Bedford, NY. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Goldilocks Therapeutics, Inc.
![]() Goldilocks Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Goldilocks Therapeutics, Inc. engages in the development of drug delivery technology for kidney tubules. It offers treatment for acute kidney injury (AKI), polycystic kidney disease (PKD), and other under-treated kidney conditions by leveraging the Company’s proprietary mesoscale nanoparticles (MNPs). The company was founded by Arthur J. Klausner, Daniel A. Heller, and Edgar A. Jaimes in 2018 and is headquartered in Bedford, NY. | Commercial Services |
- Borsa valori
- Insiders
- Edgar A. Jaimes